Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

UCITS Alternative Index global up 0.14% in February, 1.17% year to date

Monday, March 04, 2013
Opalesque Industry Update - The February performance figures for the UCITS Alternative Index Global revealed gains of 0.14% in February, up 1.17% in 2013. The UCITS Alternative Index Funds of Funds does slightly better with a progression of 0.23% and 1.54% for the year. The two best performing strategy indices are the UAI FX and the UAI Long/Short Equity, up respectively 0.56% and 0.40%. They are followed by the UAI Equity Market Neutral and the UAI Emerging Markets (up 0.25% and 0.23%). On the negative side, the UAI CTA loses -0.80%, while the UAI Commodities retraces by -0.40%. With 2.39%, the UAI Long/Short Equity is the best performing strategy index since the beginning of the year.

UAI Blue Chip:
The UCITS Alternative Index Blue Chip declines by -0.15% in February and retraces back to 1.03% for the year. The UAI Blue Chip suffered from losses in its Emerging Markets, Equity and Macro components, only partially offset by gains in its Multi-Strategy, FX and Commodities strategies.

UAIX Indices:
The UAIX indices display mixed results this month. The UAIX Long/Short Equity and the UAIX Multi-Strategy are the best performers with 0.44% and 0.30%. The UAIX Fixed Income Developed Markets rise by 0.09%, while the UAIX Fixed Income Global is up 0.01%. The UAIX CTA, best performer last month, is flat in February. On a year to date basis, the UAIX CTA is up 2.63%, followed by the UAIX Long/Short Equity, up 2.13%, and the UAIX Emerging Markets, up 1.65%.

AUM and number of funds:
In February 2013, the total assets managed by single UCITS hedge funds increased to EUR 143 billion. Fixed Income and Equity funds record the largest inflows. The UCITS Alternative Index is currently composed of more than 870 constituent UCITS hedge funds and funds of hedge funds.

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for